PharmaShots Weekly Snapshots (June 10 – June 14, 2024)

Share this

PharmaShots Weekly Snapshots (June 10 – June 14, 2024)

This week PharmaShots’ news was all about the updates on Clinical Trials, Pharma, Biotech, COVID-19, Regulatory & MedTech. Check out our full report below:

Eli Lilly Reports the P-II (SYNERGY-NASH) Study Data of Tirzepatide for Treating Metabolic Dysfunction-Associated Steatohepatitis (MASH)

Read More: Eli Lilly                                                                                                       

Moderna Reports the P-III Study Data of mRNA-1083 Vaccine Against Influenza and COVID-19

Read More: Moderna                                                                                                   

Junshi Biosciences Reports the P-III Trial Data of Toripalimab Plus Bevacizumab to Treat Advanced Hepatocellular Carcinoma (HCC)

Read More: Junshi Biosciences                                                                                   

Palatin Technologies Reports the Commencement of P-II Trial Evaluating Bremelanotide to Treat Obesity

Read More: Palatin Technologies                                                                               

Pfizer Reports the P-III Trial Data of Fordadistrogene Movaparvovec for Duchenne Muscular Dystrophy

Read More: Pfizer                                                                                                         

BeiGene to Highlight Data from P-III (SEQUOIA) Study of Brukinsa in Combination with Venetoclax for CLL/SLL at EHA2024

Read More: BeiGene                                                                                                 

Editas Medicine to Highlight the P-I/II/III (RUBY) Study Data of Reni-Cel for Treating Sickle Cell Disease at EHA 2024

Read More: Editas Medicine


Roche’s Alecensa (Alectinib) Receives the EC’s Approval as an Adjuvant Treatment for Early-Stage Lung Cancer

Read More: Roche                                                                                                        

GSK’s Arexvy Gains the US FDA’s Approval for Expanded Age Indication to Prevent RSV Lower Respiratory Tract Disease

Read More: GSK                                                                                                           

AstraZeneca Reports the US FDA’s sNDA Acceptance of Tagrisso to Treat Lung Cancer

Read More: AstraZeneca                                                                                               

Zymeworks Reports the NMPA’s BLA Acceptance of Zanidatamab to Treat Biliary Tract Cancer

Read More: Zymeworks                                                                                             

Ipsen’s Iqirvo (Elafibranor) Gains the US FDA’s Accelerated Approval for Treating Primary Biliary Cholangitis

Read More: Ipsen                                                                                                         

The US FDA Grants Emergency Use Authorization to Roche’s Four-In-One Nucleic Acid Test

Read More: Roche                                                                                                        

Regeneron’s Kevzara (Sarilumab) Gains the US FDA’s Approval to Treat Active Polyarticular Juvenile Idiopathic Arthritis (PJIA)

Read More: Regeneron                                                                                                 

The Canadian Intellectual Property Office (CIPO) Issues Notice of Allowance for Patent Covering Palisade Bio’s PALI-2108 for Treating Ulcerative Colitis

Read More: Palisade Bio                                                                                              

60 Degrees Pharmaceuticals’ Tafenoquine Gains the US FDA’s Orphan Drug Designation to Treat Acute Babesiosis

Read More: 60 Degrees Pharmaceuticals                                                              

AstraZeneca’s Farxiga (Dapagliflozin) Bags the US FDA’s Approval to Treat Type-2 Diabetes in Pediatric Patients

Read More: AstraZeneca                                                                                             

LEO Pharma’s Adbry (tralokinumab-ldrm) Autoinjector Receives the US FDA’s Approval to Treat Moderate-to-Severe Atopic Dermatitis (AD)

Read More: LEO Pharma                                                                                           

Innovent’s IBI343 Gains the US FDA’s Fast Track Designation to Treat Pancreatic Cancer

Read More: Innovent                                                                                                 

BMS Reports the US FDA’s Accelerated Approval of Augtyro to Treat Locally Advanced or Metastatic Solid Tumors

Read More: BMS                                                                                                        


Flagship Pioneering and ProFound Therapeutics Team Up with Pfizer to Discover Novel Therapies to Treat Obesity

Read More: Flagship Pioneering & ProFound                                                         

Ochre Bio and GSK Team Up to Explore the Drivers of Liver Disease

Read More: Ochre Bio & GSK                                                                                    

AbbVie Teams Up FutureGen to Advance Next-Generation Therapy to Address Inflammatory Bowel Disease

Read More: Abbvie                                                                                                       


DeepQure Reports the US FDA’s IDE Approval of HyperQure for Treating Resistant Hypertension

Read More: DeepQure                                                                                                 

The US FDA Clears Abbott’s Two New Over-The-Counter Continuous Glucose Monitoring Systems

Read More: Abbott                                                                                                    

Providence Medical’s CORUS Navigation Access System Gains the US FDA’s Clearance for Use in Posterior Spinal Fusion Procedures

Read More: Providence Medical                                                                                

Venus Medtech Reports First Implantation of the VenusP-Valve in its Pivotal Trial Across the US

Read More: Venus Medtech                                                                                   


Mira Pharmaceuticals Reports Preclinical Data of Ketamir-2 to Treat Depression

Read More: Mira Pharmaceuticals                                                                            


Alvotech and STADA Extend their Strategic Partnership Covering AVT03 (Biosimilar, Denosumab)

Read More: Alvotech & STADA                                                                                  


Moderna Reports the P-III Study Data of mRNA-1283 Vaccine to Prevent COVID-19

Read More: Moderna                 

Related Post: PharmaShots Weekly Snapshots (June 03 – June 07, 2024)                                                                                  

Disha Nankani

Disha is a content writer at PharmaShots. She is passionate and curious about recent updates and developments in MedTech and Pharma industry. She covers news related to clinical trial results and updates. She can be contacted at connect@pharmashots.com.

Share this article on WhatsApp, LinkedIn and Twitter

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions